Vaccines are 'long shots', UK's chief medical officer warns

Vaccines are “long shots” and people should not rely on the swift development of one for Covid-19, the UK government’s chief scientific adviser has warned.

A group of Oxford University researchers will begin clinical trials for a coronavirus vaccine next week but Sir Patrick Vallance says expectations need to be tempered.

Writing in The Guardian, Sir Patrick wrote: “All new vaccines that come into development are long shots; only some end up being successful, and the whole process requires experimentation.”

Sign up to our daily newsletter

The i newsletter cut through the noise

“Coronavirus will be no different and presents new challenges for vaccine development," he added.

People have been warned not to rely on a vaccine for Covid-19 to solve the pandemic crisis

“This will take time, and we should be clear it is not a certainty.”

His warning came as Sarah Gilbert, professor of vaccinology at Oxford University, said her team hopes to begin clinical trials towards the end of next week.

She acknowledged nobody can be “completely certain” that it is possible to find a vaccine for Covid-19, but the prospects are “very good”.

And she said that alongside these trials, preparations need to be made to manufacture the vaccine in large amounts.

Prof Gilbert told the BBC’s Andrew Marr Show that trials need to be done to see if it is possible to find a workable vaccine.

Prof Gilbert said her team is currently waiting for final safety tests and final approvals for clinical trials to start.

In the meantime, permission has been given to recruit volunteers, take blood tests, explain the process and check their health status, she said.

Prof Gilbert said: “By the time we have all the approvals for the vaccine ready, we should have a good pool of volunteers to draw from and we should be able to get going quite quickly.”

It is difficult to know when a vaccine might be ready, Prof Gilbert said, as there are many complex stages in vaccine development.

These start with immunising healthy people aged 18 to 55, before moving into older age groups, looking at the safety and immune response to the vaccine.

Half of all the trial volunteers will get the new coronavirus vaccine and the other half will get a vaccine licensed to protect against meningitis. Volunteers will not know what they are given, she said.

Scientists need to be able to demonstrate the vaccine works, and that is affected by how much virus transmission there is at the time testing is happening.

Prof Gilbert also said her team has gone through stages of vaccine development that usually take five years in just four months.

Sir Jeremy Farrar, a member of the government's Scientific Advisory Group for Emergencies (Sage), said he was “optimistic” about finding a vaccine but that finding a safe and effective treatment for the latest strain was “not a given”.

He told Sky News’s Sophy Ridge On Sunday: “I hope we would have a vaccine towards the end of this year - but that’s a vaccine in a vial, it’s a vaccine that we believe to be safe, a vaccine we think might be effective.

“I think it’s crucial to realise having a vaccine in itself, in say a million doses, which you know to be safe and you believe to be effective. That is not the end game.

“The end game is making sure that it is truly effective. It’s effective in the elderly, effective in young children, effective right across the age group in all populations.

“And then you have to manufacture that in billions of doses to administer them to the world.”

Meanwhile, Sir Patrick has been put in charge of a government taskforce which will support efforts to rapidly develop a vaccine as soon as possible.

As well as providing industry and research institutions with the resources and support, the group will review regulations to allow quick and safe vaccine trials.

A message from the Editor:

Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.

With the coronavirus lockdown having a major impact on many of our advertisers - and consequently the revenue we receive - we are more reliant than ever on you taking out a digital subscription.

Subscribe to scotsman.com and enjoy unlimited access to Scottish news and information online and on our app. With a digital subscription, you can read more than 5 articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit https://www.scotsman.com/subscriptions now to sign up.

Our journalism costs money and we rely on advertising, print and digital revenues to help to support them. By supporting us, we are able to support you in providing trusted, fact-checked content for this website.